Stock 1558 YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Equities

1558

CNE1000023R6

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:20 26/04/2024 pm IST 		5-day change 1st Jan Change
12.8 HKD +2.40% Intraday chart for YiChang HEC ChangJiang Pharmaceutical Co., Ltd. +3.56% +34.88%
09/04 Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma MT
01/04 Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps MT

Business Summary

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceutical products. The Company is also engaged in the research and development, marketing and distribution of pharmaceuticals. The products of the Company include anti-viral drugs, endocrine and metabolic drugs and cardiovascular drugs. Its main products include Kewei, Ertongshu, Oumeining, Xinhaining and Xining.

Sales per Business

HKD in Million2022Weight2023Weight Delta
Anti-viral Drugs
88.7 %
3,624 83.2 % 6,166 88.7 % +70.17%
Other Medical Products
4.1 %
323 7.4 % 286 4.1 % -11.54%
Cardiovascular Drugs
2.9 %
175 4.0 % 203 2.9 % +16.55%
Endocrine and Metabolic Drugs
2.6 %
132 3.0 % 181 2.6 % +37.45%
Anti-infectives Drugs
1.7 %
101 2.3 % 118 1.7 % +16.52%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
4,355 100.0 % 6,956 100.0 % +59.72%

Managers

Managers TitleAgeSince
Jun Cai Jiang CEO
 Chief Executive Officer 42 04/15/04
Qiang Zhang DFI
 Director of Finance/CFO 49 23/18/23
Hao Chen BRD
 Director/Board Member 49 01/09/01
Shuang Li BRD
 Director/Board Member 43 07/05/07
Dan Jin Wang BRD
 Director/Board Member 54 27/06/27
Qi Yun Peng IRC
 Investor Relations Contact 34 01/16/01
Wai Chiu Wong SEC
 Corporate Secretary 69 25/22/25

Members of the board

Members of the board TitleAgeSince
Jian Xin Tang BRD
 Director/Board Member 59 04/15/04
Xin Fa Tang CHM
 Chairman 54 04/15/04
Jun Cai Jiang CEO
 Chief Executive Officer 42 04/15/04
Dan Jin Wang BRD
 Director/Board Member 54 27/06/27
Zhong Hua Luo BRD
 Director/Board Member 40 16/17/16
Shuang Li BRD
 Director/Board Member 43 07/05/07
Sheng Chao Wang BRD
 Director/Board Member 41 01/12/01
Jin Long Tang CHM
 Chairman 55 01/01/01
Ling Xiang BRD
 Director/Board Member 43 05/20/05
Xue Chen Li BRD
 Director/Board Member 47 25/20/25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 226,200,000 0 0 27.70 %
Stock B 1 653,767,700 243,709,300 ( 37.28 %) 0

Shareholders

NameEquities%Valuation
HEC Hong Kong Sales Co. Ltd.
34.60 %
226,200,000 34.60 % 314 M $
GUANGDONG HEC TECHNOLOGY HOLDING CO., LTD
3.337 %
21,815,200 3.337 % 30 M $
AXA Investment Managers Asia (Singapore) Ltd.
0.0576 %
376,400 0.0576 % 523 256 $
Dimensional Fund Advisors Ltd.
0.0512 %
334,594 0.0512 % 465 139 $
Dalton Strategic Partnership LLP
0.0343 %
224,000 0.0343 % 311 396 $
Banque Degroof Petercam Luxembourg SA
0.0306 %
200,000 0.0306 % 278 032 $
Xin Fa Tang
0.0199 %
130,400 0.0199 % 181 277 $
Fullgoal Fund Management Co., Ltd.
0.0153 %
100,000 0.0153 % 139 016 $
Mandarine Gestion SA
0.0118 %
77,400 0.0118 % 107 598 $
Dan Jin Wang
0.0103 %
67,200 0.0103 % 93 419 $
NameEquities%Valuation
Shenzhen HEC Industrial Development Co., Ltd.
100.00 %
226,200,000 100.00 % 314 M $

Company contact information

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

No. 38, Binjiang Road Yidu

443300, Yichang

+

http://cj.hec.cn/en/index.aspx
address YiChang HEC ChangJiang Pharmaceutical Co., Ltd.(1558)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
11.85 CNY
Average target price
12.94 CNY
Spread / Average Target
+9.22%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. Stock YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
+34.88% 1.44B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1558 Stock
  4. Company YiChang HEC ChangJiang Pharmaceutical Co., Ltd.